<DOC>
	<DOCNO>NCT02759978</DOCNO>
	<brief_summary>Infective endocarditis ( IE ) frequent serious complication implant intracardiac prosthetic material , high morbidity mortality . Therefore , study aim improve outcome IE , focus patient intracardiac prosthetic material . In study investigator deal research question diagnosis ( microbiological , imaging , expert opinion ) treatment IE ( antimicrobial agent surgical ) , order improve clinical component ultimately aim improve outcome .</brief_summary>
	<brief_title>Individualized Diagnosis Endocarditis Its Therapy With Focus Infected Prosthetic materiAL</brief_title>
	<detailed_description>Rationale Infective endocarditis ( IE ) frequent serious complication implant intracardiac prosthetic material , high morbidity mortality . The number procedures prosthetic material implant heart increase , age comorbidity treat subject . In current clinical practice diagnosis infect intracardiac prosthetic material often difficult lack sensitivity available diagnostic armamentarium IE . As general rule , first line treatment intracardiac prosthetic material relate endocarditis consist surgical prosthesis removal , combine appropriate antimicrobial therapy . The exception encompass uncomplicated prosthetic valve endocarditis ( PVE ) . PVE actually fair chance successful medical treatment alone ( &gt; 50 % ) , depend causative micro-organism . Although evidence consensus regard first line treatment , surgical removal always possible associate high risk , technical limitation , unwillingness patient undergo invasive surgical procedure . Second third line treatment include surgery , consist antimicrobial therapy biofilm-penetrating agent predetermine timespan ( second line ) life-long suppressive antimicrobial therapy ( third line ) . These treatment alternative situation wherein first line treatment feasible unwanted . Although extensively investigate , treatment consider suboptimal . Therefore research necessary . More research need diagnose IE accurate prompt , current diagnostic criterion ( modify Duke criterion ) IE insufficient unclear best allocate non-invasive imaging technique , especially intracardiac prosthetic material . More research also need verify indication optimize use second third line treatment patient intracardiac prosthetic material . Objectives Primary To define diagnostic value combination 18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose positron emission tomography ( 18F-FDG PET ) electrocardiogram-gated multidetector compute tomography angiography ( ECG-gated MD-CTA ) patient suspect IE , particular intracardiac prosthetic material , add standard diagnostic work-up IE . Secondary - To define predictive value MD-CTA 18F-FDG PET regard relapse rate mortality IE ; - To identify source false positive false negative result MD-CTA 18F-FDG PET ( e.g . effect use antimicrobial therapy image finding ) ; - To identify best MD-CTA 18F-FDG PET scan protocol ; - To define role 18F-FDG PET find infectious lesion body ; - To assess compare current clinical practice patient intracardiac prosthetic material related infection foreign material remove ; determine outcome second third line treatment compare first line treatment , determine predictor outcome ; - To investigate potential therapeutic drug monitoring ( TDM ) improve antimicrobial therapy patient suspect IE , particular intracardiac prosthetic material : - peak blood concentration aim IE flucloxacillin , rifampicin , cefazolin , cefuroxime , ceftriaxone , amoxicillin , penicillin ; fluconazole , flucytosine , amphotericin-B ? - peak blood concentration aim gentamicin IE ? - peak blood concentration aim vancomycin intracardiac prosthetic material relate IE ? - blood concentration aim IE voriconazole ? - To investigate antimicrobial concentration resect cardiac tissue ( e.g . heart valve vegetation remove base medical indication ) patient IE treat medically antimicrobial subsequently operate upon . Study design Prospective multicentre observation study , University Medical Center Groningen ( UMCG ) Groningen lead centre . Study population Patients ( ≥18 year ) IE suspect accord Britisch Sociaty Antimicrobial Chemotherapy ( BSAC ) criterion 2012 . Main study parameters/endpoints Number clinically identify ( prosthetic material relate ) endocarditis episode , accord ( multiple ) constellation ( ) diagnostic criterion versus number `` true '' ( prosthetic material relate ) endocarditis episode , accord gold standard `` expert opinion 12 month ( +/- 2 week ) follow-up '' ( base clinical reasoning , modify Duke criterion , finding surgery pathology ) .</detailed_description>
	<mesh_term>Endocarditis</mesh_term>
	<criteria>patient present participate hospital age ≥18 year BSACcriteria 2012 : suspicion infective endocarditis , retain differential diagnosis clinical reasoning , without alternative diagnosis fulfil inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Imaging</keyword>
	<keyword>Computed Tomography</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Leukocyte Scintigraphy</keyword>
	<keyword>Microbiological diagnostics</keyword>
	<keyword>Sonication</keyword>
	<keyword>Drug Monitoring</keyword>
	<keyword>Cardiac Surgery</keyword>
</DOC>